Communiqués Samsung Biologics Co.,Ltd.

Actions

A207940

KR7207940008

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 03/06/2024			Varia. 5j.	Varia. 1 janv.
752 000 ^KRW	+3,01 %		+0,13 %	-1,05 %

31/05	Samsung Biologics vise à réduire les émissions de gaz à effet de serre d'ici 2030	MT
23/05	La FDA américaine approuve Opuviz, le médicament de Samsung Bioepis contre les maladies oculaires	MT

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Samsung Biologics : Innovative solutions for bioprocessing challenges how MSAT drives efficient tech transfer	27/05	PU
Samsung Biologics Reports First Quarter 2024 Financial Results	25/04	AQ
Samsung Life Science Fund Invests in BrickBio	20/03	AQ
CEO IR Newsletter : 2024 AGM Wrap Up	15/03	PU
Samsung Biologics : hosts 13th Annual General Meeting of Shareholders	15/03	PU
Samsung Biologics signs MOU with Seoul National University to foster bio experts	01/03	AQ
Samsung Biologics awarded Leadership status by CDP for climate action efforts	14/02	AQ
Samsung Biologics partners with LegoChem Biosciences for ADC development and manufacturing	08/02	AQ
Samsung chair found not guilty of charges connected to 2015 merger	05/02	AQ
Samsung chief Lee Jae-yong is acquitted of financial crimes related to 2015 merger	05/02	AQ
Samsung chief acquitted in controversial 2015 merger case	05/02	AQ
Samsung C&T to invest in future growth and enhance shareholder value on foundation of steady performance	01/02	AQ
Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating	23/01	AQ
Samsung Biologics : to present at the 42nd Annual J.P. Morgan Healthcare Conference	26/12	PU
S-Glyn™ : Optimizing N-Glycan profiles and their effector functions using a Design-of-Experiments approach	17/12	PU
Samsung Biologics engages suppliers to advance global decarbonization targets	29/11	AQ
Prosecutor requests 5 years in prison for Samsung president over fraud	17/11	AQ
Samsung Biologics Reports Third Quarter 2023 Financial Results	26/10/23	AQ
Samsung Biologics : to showcase strengthened development capabilities and business expansion updates at CPHI 2023	19/10/23	PU
Samsung Biologics Reports Second Quarter 2023 Financial Results	26/07/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Samsung Biologics Co.,Ltd.

Actions

A207940

KR7207940008

Communiqués

Filtres